Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tarsus Pharmaceuticals Inc (NQ: TARS ) 47.30 +2.81 (+6.32%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Tarsus Pharmaceuticals Inc < Previous 1 2 Next > Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket October 28, 2024 Via Benzinga TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024 August 08, 2024 TARS stock results show that Tarsus Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session May 13, 2024 Via Benzinga Simple Ways To Stay With Trends: The Week In Charts May 12, 2024 Has the market made its all-time highs? In this video I cover the stock and crypto markets. Via Talk Markets Analyst Ratings For Tarsus Pharmaceuticals May 09, 2024 Via Benzinga A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts February 29, 2024 Via Benzinga Earnings Scheduled For February 27, 2024 February 27, 2024 Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. Via Benzinga Tarsus Pharmaceuticals's Earnings: A Preview February 26, 2024 Via Benzinga Tarsus Pharmaceuticals - Mixed Projections February 02, 2024 Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Via Talk Markets Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session July 26, 2024 Via Benzinga Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2 May 09, 2024 Via Benzinga Recap: Tarsus Pharmaceuticals Q3 Earnings November 09, 2023 Via Benzinga Earnings Preview: Tarsus Pharmaceuticals November 08, 2023 Via Benzinga Expert Ratings for Tarsus Pharmaceuticals September 11, 2023 Via Benzinga What 6 Analyst Ratings Have To Say About Tarsus Pharmaceuticals August 14, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session May 09, 2024 Via Benzinga TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 May 08, 2024 TARS stock results show that Tarsus Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday February 28, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday January 29, 2024 U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported... Via Benzinga Topics Stocks Exposures US Equities HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To Know July 26, 2023 Via Benzinga Tarsus Pharmaceuticals Stock Scores Relative Strength Rating Upgrade December 21, 2023 On Thursday, Tarsus Pharmaceuticals stock reached a key technical milestone, seeing its Relative Strength Rating jump to 91 from 84. Via Investor's Business Daily Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session November 10, 2023 Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results. Via Benzinga HC Wainwright & Co. Maintains Buy Rating for Tarsus Pharmaceuticals: Here's What You Need To Know November 10, 2023 Via Benzinga Big Stocks Moving Higher On Friday: Synaptics Reports Q1 Beat; Joins Lyft, Hologic, Blink Charging November 10, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Friday. Shares of Synaptics Incorporated (NASDAQ: SYNA) rose sharply on Friday after the company reported better-than-expected... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Tuesday's Intraday Session August 01, 2023 Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session July 31, 2023 Via Benzinga Earnings Scheduled For November 9, 2023 November 09, 2023 Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnings at $0.30 per share on revenue of $265.00 million. Via Benzinga Tarsus Pharma Shares Under Pressure: Analyst Says Concerns Over Adverse Event Profile Overblown July 25, 2023 The FDA approved Tarsus Pharmaceuticals Inc's (NASDAQ: TARS) Xdemvy (lotilaner ophthalmic solution) 0.25% for Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session July 25, 2023 Via Benzinga Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session July 25, 2023 Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54. Via Benzinga < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
